Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phaseIIItrials

Author:

Simpson E.L.1,Lacour J.‐P.2,Spelman L.3ORCID,Galimberti R.4,Eichenfield L.F.5,Bissonnette R.6ORCID,King B.A.7,Thyssen J.P.8,Silverberg J.I.9ORCID,Bieber T.10,Kabashima K.11,Tsunemi Y.12,Costanzo A.13,Guttman‐Yassky E.14ORCID,Beck L.A.15,Janes J.M.16,DeLozier A.M.16,Gamalo M.16,Brinker D.R.16,Cardillo T.16,Nunes F.P.16,Paller A.S.17,Wollenberg A.18,Reich K.1920

Affiliation:

1. Department of Dermatology Oregon Health and Science University Portland OR USA

2. Department of Dermatology University Hospital of Nice Nice France

3. Veracity Clinical Research Brisbane Australia

4. Hospital Italiano de Buenos Aires Buenos Aires Argentina

5. University of California San Diego and Rady Children's Hospital San Diego CA USA

6. Innovaderm Research Montreal QC Canada

7. Yale University School of Medicine New Haven CT USA

8. Department of Dermatology and Allergy Herlev and Gentofte Hospital University of Copenhagen Copenhagen Denmark

9. Department of Dermatology George Washington University School of Medicine Washington DC USA

10. Department of Dermatology and Allergy University of Bonn Bonn Germany

11. Department of Dermatology Kyoto University Kyoto Japan

12. Department of Dermatology Saitama Medical University Saitama Japan

13. Humanitas University and Dermatology Unit Humanitas Research Hospital Milan Italy

14. Department of Dermatology Icahn School of Medicine at Mount Sinai New York NY USA

15. Department of Dermatology University of Rochester Medical Center Rochester NY USA

16. Lilly Research Laboratory Eli Lilly and Company Indianapolis IN USA

17. Departments of Dermatology and Pediatrics Northwestern University Feinberg School of Medicine Chicago IL USA

18. Department of Dermatology and Allergology Ludwig Maximillian University Munich Germany

19. Translational Research in Inflammatory Skin Diseases Institute for Health Services Research in Dermatology and Nursing University Medical Center Hamburg‐Eppendorf Skinflammation® Center Hamburg Germany

20. Dermatologikum Berlin Berlin Germany

Funder

Eli Lilly and Company

Publisher

Wiley

Subject

Dermatology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3